List of Excipients in API triamterene and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing triamterene and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Mylan Pharmaceuticals Inc | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | triamterene and hydrochlorothiazide | 0378-1352 | CELLULOSE, MICROCRYSTALLINE | |
| Mylan Pharmaceuticals Inc | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | triamterene and hydrochlorothiazide | 0378-1352 | CROSCARMELLOSE SODIUM | |
| Mylan Pharmaceuticals Inc | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | triamterene and hydrochlorothiazide | 0378-1352 | D&C YELLOW NO. 10 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing triamterene and hydrochlorothiazide
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 | CELLULOSE, MICROCRYSTALLINE |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 | CROSCARMELLOSE SODIUM |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 | D&C YELLOW NO. 10 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for triamterene and hydrochlorothiazide
Excipient focus: ALCOHOL
triamterene and hydrochlorothiazide drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| AvKARE | triamterene and hydrochlorothiazide | 42291-841 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
triamterene and hydrochlorothiazide drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| AvKARE | triamterene and hydrochlorothiazide | 42291-841 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
triamterene and hydrochlorothiazide drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| AvKARE | triamterene and hydrochlorothiazide | 42291-841 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
triamterene and hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-049 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
triamterene and hydrochlorothiazide drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| AvKARE | triamterene and hydrochlorothiazide | 42291-841 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
triamterene and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYLPYRIDINIUM CHLORIDE
triamterene and hydrochlorothiazide drug variants containing CETYLPYRIDINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | triamterene and hydrochlorothiazide | 33342-467 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing CETYLPYRIDINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77492
triamterene and hydrochlorothiazide drug variants containing CI 77492
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7437 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7438 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing CI 77492
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77891
triamterene and hydrochlorothiazide drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7437 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7438 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID
triamterene and hydrochlorothiazide drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | triamterene and hydrochlorothiazide | 21695-839 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7437 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7438 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
triamterene and hydrochlorothiazide drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| Quality Care Products LLC | triamterene and hydrochlorothiazide | 35356-974 |
| Medsource Pharmaceuticals | triamterene and hydrochlorothiazide | 45865-402 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
triamterene and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
triamterene and hydrochlorothiazide drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | triamterene and hydrochlorothiazide | 33342-467 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
triamterene and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-049 |
| STAT Rx USA LLC | triamterene and hydrochlorothiazide | 16590-338 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
triamterene and hydrochlorothiazide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-049 |
| STAT Rx USA LLC | triamterene and hydrochlorothiazide | 16590-338 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
triamterene and hydrochlorothiazide drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
triamterene and hydrochlorothiazide drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-1270 |
| Northwind Pharmaceuticals LLC | triamterene and hydrochlorothiazide | 51655-217 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
triamterene and hydrochlorothiazide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
triamterene and hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | triamterene and hydrochlorothiazide | 33342-467 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
triamterene and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
triamterene and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
triamterene and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
triamterene and hydrochlorothiazide drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
triamterene and hydrochlorothiazide drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| Rebel Distributors Corp | triamterene and hydrochlorothiazide | 21695-839 |
| Macleods Pharmaceuticals Limited | triamterene and hydrochlorothiazide | 33342-467 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
triamterene and hydrochlorothiazide drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 68788-8624 |
| REMEDYREPACK INC | triamterene and hydrochlorothiazide | 70518-4083 |
| REMEDYREPACK INC | triamterene and hydrochlorothiazide | 70518-4351 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
triamterene and hydrochlorothiazide drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-536 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-5801 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
triamterene and hydrochlorothiazide drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | triamterene and hydrochlorothiazide | 21695-496 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
triamterene and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| Aidarex Pharmaceuticals LLC | triamterene and hydrochlorothiazide | 33261-952 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
triamterene and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
triamterene and hydrochlorothiazide drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| AvKARE | triamterene and hydrochlorothiazide | 42291-841 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN POTASSIUM
triamterene and hydrochlorothiazide drug variants containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-049 |
| STAT Rx USA LLC | triamterene and hydrochlorothiazide | 16590-338 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
triamterene and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Bryant Ranch Prepack | triamterene and hydrochlorothiazide | 71335-1039 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
triamterene and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-049 |
| STAT Rx USA LLC | triamterene and hydrochlorothiazide | 16590-338 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
triamterene and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
triamterene and hydrochlorothiazide drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-049 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
triamterene and hydrochlorothiazide drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | triamterene and hydrochlorothiazide | 33342-467 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7437 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7438 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
triamterene and hydrochlorothiazide drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
triamterene and hydrochlorothiazide drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | triamterene and hydrochlorothiazide | 33342-467 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: POWDERED CELLULOSE
triamterene and hydrochlorothiazide drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Blenheim Pharmacal Inc | triamterene and hydrochlorothiazide | 10544-076 |
| PD-Rx Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 43063-424 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
triamterene and hydrochlorothiazide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Excipient focus: SAND
triamterene and hydrochlorothiazide drug variants containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7437 |
| A-S Medication Solutions | triamterene and hydrochlorothiazide | 50090-7438 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
triamterene and hydrochlorothiazide drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
triamterene and hydrochlorothiazide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
triamterene and hydrochlorothiazide drug variants containing SODIUM BICARBONATE
triamterene and hydrochlorothiazide drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
triamterene and hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
triamterene and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
triamterene and hydrochlorothiazide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| Sandoz Inc | triamterene and hydrochlorothiazide | 0781-2074 |
| Marlex Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 10135-581 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
triamterene and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Lannett Company Inc | triamterene and hydrochlorothiazide | 0527-1632 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
triamterene and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-1352 |
| Actavis Pharma Inc | triamterene and hydrochlorothiazide | 0591-0424 |
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-3583 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
